Karyopharm Therapeutics, Inc. (KPTI)
9.67
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
9.675
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Market Cap : 177.39M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 44.59B |
| Baxter International, Inc. | 11.10B |
| Bruker Corp. | 5.816B |
| Catalyst Pharmaceuticals, Inc. | 2.987B |
| Agios Pharmaceuticals, Inc. | 1.714B |
Market Cap Related Metrics
| PS Ratio | 0.7227 |
| PEG Ratio | -0.0021 |
| Price | 9.67 |
| Earnings Yield | -171.9% |
| PEGY Ratio | -0.0021 |